Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q2 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 +0.06%
Revenue Growth %: +5.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +5.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- MSCI acquires First Street for $120M to expand climate risk data
- JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
